BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 2002

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

gemcitabine hydrochloride

DRUG

ixabepilone

Trial Locations (1)

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00043095 - BMS-247550 and Gemcitabine in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter